New York State Teachers Retirement System Sells 43,676 Shares of Kenvue Inc. (NYSE:KVUE)

New York State Teachers Retirement System trimmed its holdings in shares of Kenvue Inc. (NYSE:KVUE - Free Report) by 2.8% during the first quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 1,518,745 shares of the company's stock after selling 43,676 shares during the period. New York State Teachers Retirement System owned approximately 0.08% of Kenvue worth $36,420,000 as of its most recent filing with the SEC.

Several other large investors also recently modified their holdings of KVUE. LaFleur & Godfrey LLC raised its position in shares of Kenvue by 29.8% during the fourth quarter. LaFleur & Godfrey LLC now owns 81,300 shares of the company's stock worth $1,736,000 after purchasing an additional 18,650 shares during the period. IFP Advisors Inc increased its stake in Kenvue by 168.4% during the 4th quarter. IFP Advisors Inc now owns 12,197 shares of the company's stock valued at $263,000 after purchasing an additional 7,652 shares in the last quarter. Proficio Capital Partners LLC acquired a new position in Kenvue during the fourth quarter worth $1,643,000. Versor Investments LP bought a new position in shares of Kenvue in the fourth quarter valued at $333,000. Finally, QRG Capital Management Inc. acquired a new position in shares of Kenvue during the fourth quarter valued at about $218,000. Institutional investors and hedge funds own 97.64% of the company's stock.

Wall Street Analysts Forecast Growth

KVUE has been the topic of several recent research reports. UBS Group raised their price target on shares of Kenvue from $24.00 to $25.00 and gave the company a "neutral" rating in a research report on Friday, May 9th. Barclays lifted their target price on Kenvue from $22.00 to $23.00 and gave the company an "equal weight" rating in a research report on Monday, May 12th. Evercore ISI initiated coverage on Kenvue in a research report on Monday, March 24th. They issued an "in-line" rating and a $25.00 price target for the company. Redburn Atlantic began coverage on shares of Kenvue in a report on Thursday, April 10th. They set a "neutral" rating and a $23.50 price objective on the stock. Finally, Citigroup reiterated a "neutral" rating on shares of Kenvue in a report on Friday, June 13th. Seven research analysts have rated the stock with a hold rating and five have issued a buy rating to the stock. According to data from MarketBeat.com, Kenvue has a consensus rating of "Hold" and an average target price of $25.33.

Kenvue Stock Performance

Shares of Kenvue stock traded down $0.08 on Wednesday, reaching $20.89. 18,186,686 shares of the company traded hands, compared to its average volume of 16,124,617. The company has a 50 day moving average of $22.69 and a 200 day moving average of $22.33. The company has a debt-to-equity ratio of 0.63, a current ratio of 0.86 and a quick ratio of 0.60. Kenvue Inc. has a 52 week low of $17.67 and a 52 week high of $25.17. The firm has a market capitalization of $40.08 billion, a PE ratio of 37.98, a PEG ratio of 3.26 and a beta of 0.83.

Kenvue (NYSE:KVUE - Get Free Report) last released its earnings results on Thursday, May 8th. The company reported $0.24 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.23 by $0.01. Kenvue had a return on equity of 20.87% and a net margin of 6.90%. The business had revenue of $3.74 billion during the quarter, compared to the consensus estimate of $3.69 billion. During the same period last year, the business posted $0.28 earnings per share. The business's revenue for the quarter was down 3.9% on a year-over-year basis. Equities analysts forecast that Kenvue Inc. will post 1.14 earnings per share for the current year.

Kenvue Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Wednesday, May 28th. Stockholders of record on Wednesday, May 14th were paid a $0.205 dividend. The ex-dividend date of this dividend was Wednesday, May 14th. This represents a $0.82 annualized dividend and a dividend yield of 3.93%. Kenvue's payout ratio is 149.09%.

Kenvue Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.